None listed
Conditions
Interventions
Drug : After the detailed explanation of the purpose and method of this study, the screening test will be conducted for pathiets who have agreed in writing. Patients who meet the inclusion / exclusion
Sponsors
The Catholic University of Korea, Seoul St. Mary's Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Subjects to the following criteria are eligible for this study. ? Patients over the age of 19 years and under 70 years of age who have been diagnosed with shoulder adhesive capsulitis and complaining symptom over 2 months are included in this study. The diagnosis of adhesive capsulitis is defined as one of the following. i. Forward flexion below 100’ ii. External rotation below 45’ iii. Internal rotation below L1 level ? Patients with LDL cholesterol (130-159 mg / dL) who are in low risk group (0-1 risk factors) by determining the patient's cardiovascular risk factors. (Risk factors: smoking, high blood pressure, low density lipoprotein cholesterol ( 45 years, women> 55 years)) ? Women who are likely to become pregnant must meet the following conditions: : At least one year has been menopause, there is no chance of pregnancy by surgery / procedure, or an acceptable contraceptive method (intrauterine device-loop, mirna, double-blocking diaphragm or condom / femdom + spermicide, oral or parenteral contraceptive,). ? Patients who understand this study and agree to participate in the study
Exclusion criteria
Exclusion criteria: Exclusion Criteria To participate in this study, you must not meet the following exclusion criteria: 1. Patients with ipsilateral shoulder full thickness rotator cuff tear and labial lesion, arthritis, joint instability 2. Surgical Treatment for Ipsilateral Shoulder Disease 3. Patients with a history of ipsilateral shoulder infectious arthritis, rheumatoid arthritis, tumor, fracture 4. Patients who have previously taken statin drugs 5. Patients who have previously received intraarticular triamcinolone injections 6. Patients diagnosed with myopathy 7. Women who may be pregnant and are planning to be nursing or pregnant. 8. Lipitor tablets contain lactose, so patients with genetic problems such as galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption 9. alcoholics 10. Patients with personal or family history of hereditary muscle abnormalities 11. Patients with hypothyroidism 12. Patients receiving glecaprevir and fibrentasvir (marbitet tablet) 13. Patients with hypersensitivity to Lipitor, Triamcinolone Injection, and Components 14. Local infections, sepsis, infections without effective antimicrobial agents, systemic fungal infections, tuberculosis disease, herpes simplex keratitis, patients with previous neurological abnormalities 15. Posterior subcapsular cataract patient, glaucoma patient 16. Recent intestinal anastomosis, peptic ulcer, diverticulitis, schizophrenia, severe osteoporosis 17. Patients with uncontrolled hypertension with diastolic blood pressure above 100 mmHg, with electrolyte abnormalities 18. ???? ??? ?? ?? (aspartate aminotransferase or alanine aminotransferase >60 IU litre) 19. Patients with abnormal liver function (aspartate aminotransferase or alanine aminotransferase> 60 IU litre) 20. patient with diabetes 21. Patients with renal impairment 22. Fat embolism patient, metastatic cancer patient, Cushing syndrome patient, epilepsy patient 23. Spontaneous thrombocytopenia, purpura 24. Herpes simplex, shingles, chickenpox 25. Patients deemed inappropriate for this test by the judgment of the person in charge of the test such as mental illness Early termination criteria 1. Death of the patient 2. If hospitalization or treatment is necessary due to the development of a new important disease 3. If there is a limitation of shoulder ROM being treated due to trauma or disease 4. In case of omission of patient during follow-up 5. If the patient does not want the study to proceed anymore due to the occurrence of side effects.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Shoulder functional score (ASES score ) | — |
Secondary
| Measure | Time frame |
|---|---|
| range of motion;shoulder functional scores (Constant score, KSES score),;blood test (total cholesterol, triglyceride, HDL-cholesterol, LDL-cholesterol, AST, ALT, Urea nitrogen);shoulder ultrasonography | — |
Countries
Korea, Republic of
Contacts
Public ContactHyungjoon Kim
The Catholic University of Korea, Seoul St. Mary's Hospital
Outcome results
None listed